Drug Database
Back to search

United States· US:53675-100_4a04fed7-e3c1-dc1e-e063-6294a90a2076

ARUBA ALOE ISLAND REMEDY DAILY ULTRA ALOE

A protectives against uv-radiation for topical use product containing octinoxate, oxybenzone, registered in United States by ARUBA ALOE BALM NV. The same ATC class is registered in 2 of our 19 countries.

ATC D02BAUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedARUBA ALOE ISLAND REMEDY DAILY ULTRA …ATCD02BAREGISTER NO.US:53675-100_4a04fed7…PACKS LISTED1CHECKEDJune 3, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about octinoxate, oxybenzoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Octinoxate, oxybenzone is registered in 2 of 19 countries.

Countries holding a registration under ATC D02BA (protectives against uv-radiation for topical use), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose
Search octinoxate, oxybenzone products by name

Octinoxate, oxybenzone · ATC D02BA

2 / 19 countries

  • Canada
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OCTINOXATE, OXYBENZONE
Manufacturer
ARUBA ALOE BALM NV
Country
United States (US)
ATC code
D02BA
ATC class
Protectives against UV-radiation for topical use
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    5367510001
    1 JAR in 1 BOX (53675-100-01) / 118 mL in 1 JAR

Regulatory notes

UNII (FDA substance ID)
4Y5P7MUD51
OCTINOXATE
RxCUI 13369
DailyMed SPL labels
1 version tracked

Same class

Other records under D02BA

Protectives against uv-radiation for topical use, as other registers publish it.

All octinoxate, oxybenzone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2eee421-babd-4acb-81f0-2cc168c8b130
GET /v1/drugs/b2eee421-babd-4acb-81f0-2cc168c8b130?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "4Y5P7MUD51",
    "rxcui": "13369",
    "inchikey": "YBGZDTIWKVFICR-JLHYYAGUSA-N",
    "display_name": "OCTINOXATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "TOPICAL",
  "spl_meta": {
    "ad218ca8-103d-4cbe-b13d-6666c7d08d66": {
      "match": "brand_token",
      "title": "ARUBA ALOE ISLAND REMEDY DAILY ULTRA ALOE (OCTINOXATE, OXYBENZONE) CREAM [ARUBA ALOE BALM NV]",
      "spl_version": "3",
      "published_date": "2026-02-16"
    }
  },
  "productid": "53675-100_4a04fed7-e3c1-dc1e-e063-6294a90a2076",
  "productndc": "53675-100",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": "OCTINOXATE; OXYBENZONE",
  "proprietary_name": "ARUBA ALOE ISLAND REMEDY DAILY ULTRA ALOE",
  "active_ingred_unit": "mg/mL; mg/mL",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG",
  "nonproprietary_name": "OCTINOXATE, OXYBENZONE",
  "start_marketing_date": "20101101",
  "active_numerator_strength": "75; 45"
}
API referenceMCP serverPlans

See everything about octinoxate, oxybenzone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console